We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Collaboration Initiated for Heart Disease Research

By MedImaging International staff writers
Posted on 20 Nov 2008
Print article
A major corporation and a British institute are planning to work together on developing new ways to improve diagnosis and treatment of cardiovascular disease.

Philips Healthcare (Best, The Netherlands) announced a new Memorandum of Understanding (MOU) for a five-year research collaboration with King's College London (UK).

Under the multi-million Euro agreement, Philips and King's College London's division of imaging sciences will develop new medical imaging research projects with a particular focus on cardiology and cardiac electrophysiology. One of the major areas of focus will be on combining different imaging technologies, such as X-ray, magnetic resonance imaging (MRI), ultrasound, and computed tomography (CT), to help clinicians navigate their way through a patient's heart during minimal-invasive procedures.

Philips and King's College London have already built a long-standing relationship, in particular through the College's division of imaging sciences, in the areas of image analysis, particularly in the field of MRI, diagnostics, and interventional guidance. The new agreement aims at the continuation of long-term collaboration in these fields and it will seek to establish new research projects into medical imaging for cardiovascular disease, cardiac arrhythmias, and pediatric diseases.

Dr. Reza Razavi, professor of pediatric cardiovascular science at King's College London and head of the division of imaging sciences, said, "We have a long history of working closely with Philips, and this new agreement will allow us to continue our research into cardiovascular disease for many more years. Through our research we hope to advance the way we diagnose and treat heart conditions and so improve the care of children and adults with cardiovascular disease.”

Steve Rusckowski, CEO of Philips Healthcare and member of the board of management of Royal Philips, added, "We believe that understanding the needs of patients and care providers ensures we create solutions that best meet their requirements and so are very proud to be working in close cooperation with Prof. Razavi, the team at King's College London and Guy's & St Thomas' Hospital. Through these innovative research projects we hope to find new ways of delivering cardiology care that will offer real benefits for patients and clinicians.”

King's, through its commercial arm, King's College London Business, is focused on creating mutually beneficial industrial collaborations of this kind as part of its translational research agenda.

Related Links:
Philips Healthcare
King's College London

New
Ultrasound-Guided Biopsy & Visualization Tools
Endoscopic Ultrasound (EUS) Guided Devices
X-Ray Illuminator
X-Ray Viewbox Illuminators
Ultrasound Imaging System
P12 Elite
Computed Tomography System
Aquilion ONE / INSIGHT Edition

Print article

Channels

Radiography

view channel
Image: The new machine algorithm can identify cardiovascular risk at the click of a button (Photo courtesy of Adobe Stock)

Machine Learning Algorithm Identifies Cardiovascular Risk from Routine Bone Density Scans

A new study published in the Journal of Bone and Mineral Research reveals that an automated machine learning program can predict the risk of cardiovascular events and falls or fractures by analyzing bone... Read more

MRI

view channel
Image: In brains of control mice (left) and PD mice (right), from bottom to top: neuronal activity in a representative animal (Photo courtesy of Ruxanda Lungu/FC)

Simple Brain Scan Diagnoses Parkinson's Disease Years Before It Becomes Untreatable

Parkinson's disease (PD) remains a challenging condition to treat, with no known cure. Though therapies have improved over time, and ongoing research focuses on methods to slow or alter the disease’s progression,... Read more

Nuclear Medicine

view channel
Image: In vivo imaging of U-87 MG xenograft model with varying mass doses of 89Zr-labeled KLG-3 or isotype control (Photo courtesy of L Gajecki et al.; doi.org/10.2967/jnumed.124.268762)

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors

Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.